NASDAQ: CPRX $360 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 76%. 1 Year Return 10%. 2021 YTD Return 5%. Since Earnings 17%.
The 52 Week Low is $2.61 set on Mon, Mar 16, 2020.
The 52 Week High is $5.27 set on Fri, Feb 21, 2020.
The All-Time High is $7.67 set on Wed, Sep 11, 2019.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Catalyst Pharmaceuticals Inc trades on the NASDAQ. CPRX's market cap is 360.00 Million.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome.
For Starters
Track your portfolio and more.
